Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Interpretation of Confidence Intervals01:19

Interpretation of Confidence Intervals

A confidence interval is a better estimate of the population than a point estimate, as it uses a range of values from a sample instead of a single value.
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
Behrens–Fisher Test00:57

Behrens–Fisher Test

The Behrens-Fisher test is a statistical method designed to address the Behrens-Fisher problem, which arises when comparing the means of two normally distributed populations with unequal variances. Unlike the Student's t-test, which assumes equal variances, the Behrens-Fisher test allows for mean comparison without this restrictive assumption. This flexibility makes it particularly valuable in scenarios where two independent samples exhibit normality but lack variance homogeneity.
This test is...
Testing a Claim about Standard Deviation01:19

Testing a Claim about Standard Deviation

A complete procedure to test a claim about population standard deviation or population variance is explained here.
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global inequities in the adoption of innovative clinical trial designs: a cross-sectional analysis of ClinicalTrials.gov.

BMJ open·2026
Same author

Basket and umbrella trials in pediatric precision medicine: a systematic review of designs, opportunities, and challenges.

BMC medical research methodology·2026
Same author

Correction: Manifesto of the collaborative alliance for research and educationin surgery: the CARES network. "Surgical research must become amilestone of progress in patient care in Italy".

Updates in surgery·2026
Same author

Motor and cognitive effects of video game training in people with multiple sclerosis: a randomized controlled trial.

European journal of physical and rehabilitation medicine·2026
Same author

Integrated comprehensive assessment for predicting weaning success in difficult-to-wean critically ill patients: the WEAN-US study.

Critical care (London, England)·2026
Same author

Identification of physiological clusters in acute hypoxemic respiratory failure patients undergoing non-invasive respiratory support using EIT-based t-SNE and spectral clustering.

Intensive care medicine experimental·2026

Related Experiment Video

Updated: May 16, 2026

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

Interpreting Non-Inferiority Across Effect Scales: A Bayesian Perspective with Clinical Translation.

Danila Azzolina1, Silvia Bressan2, Mohd Rashid Khan3

  • 1Biostatistics and Clinical Trial Biometry, Clinical Research Center DEMeTra, Department of Translational Medicine, University of Naples Federico II, Naples, Italy. danila.azzolina@unina.it.

Therapeutic Innovation & Regulatory Science
|May 14, 2026
PubMed
Summary

Choosing non-inferiority margins impacts clinical interpretation. Bayesian reanalysis of high-flow nasal cannula versus non-invasive ventilation trials shows margins can be misleading, highlighting the need for patient-centered measures like Number Needed to Harm.

Keywords:
Absolute and relative risk measuresBayesian trialsClinical interpretation of marginsCritical careNon-inferiority trialsNumber needed to harm (NNH)Paediatrics

Related Experiment Videos

Last Updated: May 16, 2026

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

Area of Science:

  • Clinical trials methodology
  • Bayesian statistics in healthcare
  • Respiratory support interventions

Background:

  • Non-inferiority margins are crucial for interpreting clinical trial results.
  • The choice of margin scale can significantly alter the clinical interpretation of treatment effects.
  • The Santos et al. trial comparing high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV) serves as a relevant case study.

Purpose of the Study:

  • To examine how non-inferiority margin selection affects clinical interpretation in interventional studies.
  • To demonstrate the utility of Bayesian reanalysis for improving the interpretability of non-inferiority margins.
  • To translate non-inferiority margins into patient-centered metrics like the Number Needed to Harm (NNH).

Main Methods:

  • Secondary Bayesian reanalysis of a published randomized controlled trial.
  • Re-expression of non-inferiority margins on Absolute Risk Reduction (ARR) and Odds Ratio (OR) scales.
  • Estimation of Bayesian probabilities for non-inferiority and benefit, and derivation of NNH.

Main Results:

  • A 0.15 ARR non-inferiority margin, initially appearing conservative, may represent a substantial relative risk increase, potentially doubling the odds of intubation.
  • Patient-centered interpretation revealed an NNH of approximately 6.7, indicating that for every seven infants treated with HFNC instead of NIV, one additional infant might require intubation.
  • The original analysis's conclusion of non-inferiority was based on a fixed absolute margin, which, when re-evaluated, showed potential for misinterpretation.

Conclusions:

  • Non-inferiority margins, derived from statistical evidence and clinical judgment, require careful interpretation as their meaning varies across effect scales.
  • Reporting transparency regarding margin interpretation is essential for accurate clinical understanding.
  • Integrating Bayesian methods and multiple non-inferiority definitions enhances the interpretability and clinical relevance of trial findings.